From Yahoo Finance: 2025-05-11 16:51:00

Jim Simons’ Renaissance Technologies is known for its groundbreaking success, utilizing quantitative analysis to predict stock movements and generate impressive returns. Simons’ Medallion Fund has produced remarkable results, with an annual return of 31.5% since its inception, making him one of the world’s wealthiest individuals. The Renaissance Institutional Diversified Alpha Fund and the Renaissance Institutional Equities Fund have both seen strong performance in 2024 and 2025, showcasing the firm’s prowess in the market. Gilead Sciences, Inc. (GILD), a biopharmaceutical company, is a popular stock pick by Renaissance Technologies, ranking 10th on their list. GILD reported a 1% decrease in total product sales for the first quarter of 2025, with HIV products being the main revenue driver. The company announced an additional $11 billion investment in the U.S. to bolster manufacturing and research capabilities, aligning with President Donald Trump’s tariff policy. ClearBridge Value Strategy highlighted GILD’s strong performance in its Q1 2025 investor letter, emphasizing the company’s growth potential. While GILD shows promise as an investment, there are AI stocks that offer higher returns within a shorter timeframe, making them more appealing options for investors.



Read more at Yahoo Finance: Is Gilead Sciences (GILD) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?